RevolKa Ltd.
PrivateLast Round
Series A
Extension
Aug 18, 2025
Total Funding Raised
$12.06M
Company Overview
RevolKa Ltd. is a biotechnology company that provides an AI-driven protein engineering technology platform called aiProtein® to create novel proteins for therapeutics and industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevolKa Ltd. Comparables
Compare RevolKa Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evozyne | 84% | |
| Cradle | 83% | |
| EvolutionaryScale | 83% |
RevolKa Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 18, 2025 | ||||
| Debt | Jul 31, 2025 | ||||
| Series A Extension | May 20, 2025 | ||||
| Series A Extension | Aug 30, 2024 | ||||
| Series A Extension | Feb 1, 2024 | ||||
Series A | May 31, 2022 |
RevolKa Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 七十七キャピタル株式会社 | Series A Extension |
| DEEPCORE Inc. | Series A Extension |
| Tohoku University Venture Partners | Seed, Series A, Series A Extension |
| スパークル株式会社 | Seed |
| The 77 Bank, Ltd. | Debt |
| SBI Investment Co., Ltd. | Series A |
| D3 LLC | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 317% MoM to 21.8K.
- Sep 9, 2025
Exhibiting at Antibody Engineering 2025 in Amsterdam, September 9-10, 2025.
RevolKa Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RevolKa Ltd.'s valuation, stock price, and market status.
Is RevolKa Ltd. a public or private company?
RevolKa Ltd. is a private company.
What is the current stock price of RevolKa Ltd.?
RevolKa Ltd. is a private company, so its shares have no public market price. Caplight tracks RevolKa Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RevolKa Ltd. worth (valuation)?
Valuation information for RevolKa Ltd. is not publicly available.
Can I buy RevolKa Ltd. stock?
RevolKa Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RevolKa Ltd.'s last funding round?
RevolKa Ltd.'s most recent funding round was Series A Extension on August 18, 2025.
Who are the main investors in RevolKa Ltd.?
Key investors in RevolKa Ltd. include DEEPCORE Inc., Tohoku University Venture Partners, SBI Investment Co., Ltd., D3 LLC.
Will RevolKa Ltd. IPO soon?
No public IPO plans have been announced for RevolKa Ltd..
How can I track RevolKa Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in RevolKa Ltd.'s shares on secondary markets.